Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows
SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Indian rupees...
Read the full articleYou might also wanna read
Biocon block deal today: Mylan may sell Rs 3,481 crore worth of shares in pharma major
According to Business Today sources, the floor price has been set at Rs 378.50 per share, a 7.9 per cent discount to Biocon's Monday closing
businesstoday.in·3d ago

Biocon Shares Rise After Mylan Exits Following Rs. 3,676-Crore Stake Sale
analyticsinsight·2d ago

Biocon shares jump 6% on reports of ₹3,481-crore block deal; Mylan likely to exit after 17 years
Fortune India·3d ago
Biocon share price climbs 5% after block deals on NSE, BSE; key details
Biocon stock rose 4.96 per cent to Rs 430.95 apiece after sources had earlier indicated that the floor price for the block deal was set at R
businesstoday.in·3d ago

11 stocks to watch on Tuesday: Biocon, BEL, Grasim, Emcure and more
Biocon, Grasim Industries, Bharat Electronics, Emcure Pharmaceuticals and Welspun Enterprises will be among the stocks in focus on Tuesday f
thehindubusinessline.com·3d ago
Emcure Pharmaceuticals buys final 12.05% Gennova stake for ₹231.87 Crore to consolidate control.
Emcure Pharmaceuticals is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 Crore to reach 100% ownership. This
Sahi·3d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.